Baotou Dongbao Bio-Tech Co.,Ltd

SZSE:300239 Stock Report

Market Cap: CN¥3.1b

Baotou Dongbao Bio-TechLtd Management

Management criteria checks 4/4

Baotou Dongbao Bio-TechLtd's CEO is Fang Liu, appointed in Sep 2021, has a tenure of 3.25 years. directly owns 0.7% of the company’s shares, worth CN¥21.93M. The average tenure of the management team and the board of directors is 4.5 years and 3.3 years respectively.

Key information

Fang Liu

Chief executive officer

CN¥777.1k

Total compensation

CEO salary percentagen/a
CEO tenure3.3yrs
CEO ownership0.7%
Management average tenure4.5yrs
Board average tenure3.3yrs

Recent management updates

Recent updates

Market Might Still Lack Some Conviction On Baotou Dongbao Bio-Tech Co.,Ltd (SZSE:300239) Even After 37% Share Price Boost

Oct 08
Market Might Still Lack Some Conviction On Baotou Dongbao Bio-Tech Co.,Ltd (SZSE:300239) Even After 37% Share Price Boost

We Like These Underlying Return On Capital Trends At Baotou Dongbao Bio-TechLtd (SZSE:300239)

Oct 01
We Like These Underlying Return On Capital Trends At Baotou Dongbao Bio-TechLtd (SZSE:300239)

Baotou Dongbao Bio-TechLtd's (SZSE:300239) Dividend Will Be Reduced To CN¥0.022

May 27
Baotou Dongbao Bio-TechLtd's (SZSE:300239) Dividend Will Be Reduced To CN¥0.022

Sentiment Still Eluding Baotou Dongbao Bio-Tech Co.,Ltd (SZSE:300239)

Feb 28
Sentiment Still Eluding Baotou Dongbao Bio-Tech Co.,Ltd (SZSE:300239)

CEO

Fang Liu (60 yo)

3.3yrs

Tenure

CN¥777,100

Compensation

Mr. Fang Liu serves as General Manager of Baotou Dongbao Bio-Tech Co.,Ltd since September 10, 2021 and serves as its Director since August 28, 2000. He served as Secretary of the Board at Baotou Dongbao Bi...


Leadership Team

NamePositionTenureCompensationOwnership
Fang Liu
GM & Director3.3yrsCN¥777.10k0.70%
CN¥ 21.9m
Haiqing Hao
Financial Director5.7yrsCN¥535.80kno data
Furong Wang
Deputy GM & Director8.2yrsCN¥526.10k0.054%
CN¥ 1.7m
Yan Liu
Deputy GM & Director3.3yrsCN¥375.90kno data

4.5yrs

Average Tenure

49.5yo

Average Age

Experienced Management: 300239's management team is considered experienced (4.5 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Fang Liu
GM & Director24.3yrsCN¥777.10k0.70%
CN¥ 21.9m
Furong Wang
Deputy GM & Director10.8yrsCN¥526.10k0.054%
CN¥ 1.7m
Yan Liu
Deputy GM & Director3.3yrsCN¥375.90kno data
Hongxia Sun
Non-Employee Supervisorless than a yearno datano data
Jun Wang
Non-Employee Supervisorless than a yearCN¥528.60k0.69%
CN¥ 21.7m
Jianhua Yu
Supervisor17yrsno data0.015%
CN¥ 453.4k
Debu Gao
Independent Director4.6yrsCN¥100.00kno data
Bin Ren
Independent Director4.6yrsCN¥100.00kno data
Aiguo Wang
Chairman3.3yrsCN¥9.60kno data
Tao Ketao Eerdun
Independent Director3.3yrsCN¥100.00kno data
Xing Zhou
Chairman of the Supervisory Board3.3yrsno datano data
Jing Wang
Independent Directorless than a yearno datano data

3.3yrs

Average Tenure

61.5yo

Average Age

Experienced Board: 300239's board of directors are considered experienced (3.3 years average tenure).


Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 07:20
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Baotou Dongbao Bio-Tech Co.,Ltd is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Shuchang LiuChangjiang Securities Co. LTD.
Jie YaoEverbright Securities Co. Ltd.